Description
Meropenem 500mg + Sulbactum 250mg Injection
Farlex Critical Care introduces Meropenem 500mg + Sulbactum 250mg Injection, a powerful combination antibiotic designed to combat severe bacterial infections. Meropenem, a carbapenem antibiotic, offers broad-spectrum efficacy, while Sulbactum, a beta-lactamase inhibitor, enhances its potency against resistant bacteria.
Our Meropenem 500mg + Sulbactum 250mg Injection is produced in state-of-the-art facilities adhering to strict quality standards, ensuring safety and effectiveness. As one of the Top Critical Care Pharma Companies in India, Farlex Critical Care is committed to delivering superior pharmaceutical products and solutions to healthcare professionals.
Key Benefits:
- Broad-Spectrum Antibiotic: Effective against a wide range of bacterial infections.
- Enhanced Potency: Sulbactum prevents the breakdown of Meropenem by beta-lactamase enzymes, prolonging its action.
- High-Quality Production: Manufactured in ISO and GMP certified facilities.
- Trusted Provider: Farlex Critical Care is a trusted name in the critical care pharmaceutical sector.
Applications:
Meropenem 500mg + Sulbactum 250mg Injection is indicated for treating severe bacterial infections including pneumonia, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. Always seek advice from a healthcare professional before use.
Why Choose Farlex Critical Care?
- We are among the Top Critical Care Pharma Companies in India.
- We offer high-quality products and comprehensive support to healthcare professionals.
- Our dedication to excellence ensures the availability of effective treatments.
For more information or to partner with us, contact Farlex Critical Care today.
